Project: Metrology for molecular radiotherapy

Molecular radiotherapy, also known as nuclear medicine therapy, specifically targets cancerous cells through the use of ‘carrier’ molecules that attach themselves to tumours or accumulate in specific parts of the body, e.g. the thyroid gland. Currently, molecular radiotherapy is not universally used, but it has the potential to become an important weapon in the fight against cancer. Molecular radiotherapy treatments are based on the measured activity of the radioactive material administered, but as different patients take up different amounts of radiation, it means that they receive different dosages. This project will validate the methods and analyse the uncertainties involved in molecular radiotherapy procedures. This will support the use of individualised patient treatments based on the absorbed dose, and lead to more effective targeted therapy and treatments.

Acronym HLT11 MetroMRT (Reference Number: HLT11)
Duration 01/06/2012 - 31/05/2015
Project Topic Metrology
Project Results
(after finalisation)
See Website
Website visit project website
Network EMRP
Call EMRP Call 2011 - Health, SI Broader Scope and New Technologies

Project partner

Number Name Role Country
1 NPL Management Limited Coordinator United Kingdom
2 Commissariat à l'énergie atomique et aux énergies alternatives Partner France
3 Cesky Metrologicky Institut Partner Czech Republic
4 Agenzia Nazionale per le nuove tecnologie, l’energia e lo sviluppo economico sostenibile Partner Italy
5 Physikalisch-Technische Bundesanstalt Partner Germany
6 VSL B.V. Partner Netherlands
7 Azienda Unità Sanitaria Locale Latina Observer Italy
8 The Christie NHS Foundation Trust Observer United Kingdom
9 Institute of Cancer Research - Royal Cancer Hospital Observer United Kingdom
10 Istituti Fisioterapici Ospitalieri Observer Italy
11 Istituto Superiore di Sanità Observer Italy
12 Lunds Universitet Observer Sweden
13 University College London Observer United Kingdom
14 Velindre National Health Service Trust Observer United Kingdom